Core Viewpoint - The article emphasizes the significance of cell biology research in various biomedical fields, including tissue barrier functions, receptor signaling networks, enzyme inhibition studies, amyloid protein research, and the future of medical revolutions [3]. Group 1: Global Hot Topics - Topic 1: Nanomedicine in Metabolic Disorders focuses on innovative nanotechnology-based approaches for diagnosing and treating metabolic diseases, highlighting advancements in targeted drug delivery systems, nano-diagnostic platforms, and integrated therapeutic systems [4]. - Topic 2: Stem Cells and 3D Cellular Models discusses the transformative impact of stem cells and tissue engineering, particularly in conjunction with 3D models and nanotechnology, on biomedical research objectives [7]. Group 2: Submission Deadlines and Journals - Submission deadline for Topic 1 is March 31, 2026, and it is associated with the journal "Artificial Cells, Nanomedicine, and Biotechnology" [5]. - Submission deadline for Topic 2 is May 31, 2026, also linked to the journal "Artificial Cells, Nanomedicine, and Biotechnology" [7]. Group 3: High-Impact Journals - The journal "Amyloid" has an impact factor of 7.4 and focuses on amyloid proteins and related diseases, covering various aspects such as etiology, epidemiology, and clinical research [11]. - The "Journal of Enzyme Inhibition and Medicinal Chemistry" has an impact factor of 5.4, concentrating on enzyme inhibitors and their role in drug development [15]. - The journal "Artificial Cells, Nanomedicine, and Biotechnology" has an impact factor of 4.5, emphasizing interdisciplinary research in artificial cells and nanomedicine [20].

Core Viewpoint - Hu Ye, a prominent biomedical scientist, has returned to China after 22 years in the U.S., criticizing the Trump administration's funding cuts to the NIH, which totaled $8.3 million, impacting critical research areas [1][3]. Group 1: Background and Career - Hu Ye served as a professor at Tulane University and has a strong academic background, having graduated from Lanzhou University and Tsinghua University, and obtained advanced degrees from the University of Texas [6][7]. - He has held various prestigious positions, including founding director of the Intelligent Molecular Diagnostics Center and has been involved in significant research projects funded by institutions like the NIH and the Gates Foundation [7][8]. Group 2: Research Impact and Funding Cuts - Hu Ye publicly warned that the proposed federal budget could reduce NIH's indirect cost reimbursement rate from 53% to 15%, which would severely affect scientific research [3]. - Specific NIH funding cuts include $3.7 million for early detection of tuberculosis and HIV in children, $3.1 million for blood-based cancer detection technology, and $1.5 million for advanced equipment procurement [3]. Group 3: Contributions to Biomedical Research - Hu Ye has focused on rapid virus detection and has published extensively in top journals, holding over 30 patents in nanomedicine [3][6]. - His laboratory developed a rapid COVID-19 testing kit that uses saliva and provides results in 15 minutes, showcasing his innovative contributions to public health [6][7]. Group 4: Future Directions at Tsinghua University - Upon returning to China, Hu Ye has taken on the role of Dean at Tsinghua University's School of Biomedical Engineering, aiming to advance research in infectious diseases, neurological disorders, and cancer diagnostics [7][8]. - His leadership is expected to enhance Tsinghua's position in the international biomedical field, as noted by the university's vice president [8].

Group 1 - The 2025 China Biomedical Engineering Conference and Innovation Medical Summit opened in Suzhou, highlighting the city's role as a hub for biomedical innovation and high-end medical device R&D [1][2] - The conference aims to encourage young scholars to showcase their talents and achievements, fostering collaboration between the China Biomedical Engineering Society and Suzhou in talent cultivation, technology R&D, and achievement transformation [1] - The conference theme is "Integration of Medicine and Engineering, Innovation Leading the Future," focusing on key areas such as artificial intelligence, smart healthcare, nanomedicine, organoids and organ-on-chip technology, regenerative medicine, medical imaging, medical robotics, biomanufacturing, and life support systems [2] Group 2 - The conference features keynote speeches from academicians, annual thematic forums, 21 sub-venues, and 15 sub-forums, along with competitions for young papers, innovative project roadshows, and entrepreneurship contests for comprehensive academic exchange and achievement display [2] - The opening ceremony included the awarding of the Huang Jiasu Biomedical Engineering Award for 2024-2025 and the presentation of fellow certificates from the China Biomedical Engineering Society [2]